Skip to main content
. 2014 Dec 11;10(12):e1004533. doi: 10.1371/journal.ppat.1004533

Figure 7. There are fewer CD3+ T cells, but not monocyte/macrophages in lymph node with natalizumab treatment.

Figure 7

(A) There were similar numbers of p28+ and SIV RNA+ cells in the axillary lymph nodes of all of animals, regardless of treatment or time of sacrifice. (B) Comparable levels of activated resident CD68+ macrophages were detected in all macaques. (C) The numbers of MAC387+ cells were similar in late and early treated versus non-treated macaques. (D) There was a reduction in CD3+ T lymphocytes from tissues of late and early natalizumab treated macaques relative to untreated controls. Each point represents the mean number of positive cells in the three tissue regions examined from a single animal. Lines and error bars indicate the mean ± SEM for each treatment group. Scale bars: 50 microns. P values calculated using unpaired t tests. P≤0.05*, p≤0.01 **.